We are live on ! Find out more
ZBH icon

Zimmer Biomet

999 hedge funds and large institutions have $23.7B invested in Zimmer Biomet in 2021 Q4 according to their latest regulatory filings, with 138 funds opening new positions, 321 increasing their positions, 334 reducing their positions, and 109 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 109

19% more call options, than puts

Call options by funds: $142M | Put options by funds: $120M

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

2% more funds holding

Funds holding: 984 → 999 (+15)

1% more capital inflows, than outflows

Capital inflows: $2.49B | Capital outflows: $2.48B

0.09% more ownership

Funds ownership: 89.22% → 89.3% (+0.09%)

4% less repeat investments, than reductions

Existing positions increased: 321 | Existing positions reduced: 334

Holders
999
Holders Change
+15
Holders Change %
+1.52%
% of All Funds
15.32%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.11%
New
138
Increased
321
Reduced
334
Closed
109
Calls
$142M
Puts
$120M
Net Calls
+$22.2M
Net Calls Change
+$26.4M

ZBH Hedge Fund Activity: Q4 2021 in Review

999 of the 6,523 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q4 2021, worth a combined $23.7B — down 13% from $27.3B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new ZBH positions and 109 closed out — a net gain of 29 holders — while 321 added to existing stakes and 334 trimmed.

The largest buyer was Vanguard Group, adding an estimated $439M. The largest seller was Wells Fargo, cutting an estimated $240M.

  • 999 institutional investors held Zimmer Biomet (ZBH) as of Q4 2021, up from 984 in Q3 2021.
  • Funds reported $23.7B of Zimmer Biomet stock for Q4 2021, down 13% quarter-over-quarter.
  • 138 funds opened new Zimmer Biomet positions in Q4 2021 and 109 closed out, a net change of +29 holders.
  • The largest Zimmer Biomet buyer in Q4 2021 was Vanguard Group, an estimated $439M added.
  • The largest Zimmer Biomet seller in Q4 2021 was Wells Fargo, an estimated $240M sold.

Based on aggregated 13F filings for Q4 2021.